152 related articles for article (PubMed ID: 25128505)
1. Infections increase risk of arterial and venous thromboses in Danish patients with systemic lupus erythematosus: 5102 patient-years of followup.
Baronaite Hansen R; Jacobsen S
J Rheumatol; 2014 Sep; 41(9):1817-22. PubMed ID: 25128505
[TBL] [Abstract][Full Text] [Related]
2. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.
Øhlenschlaeger T; Garred P; Madsen HO; Jacobsen S
N Engl J Med; 2004 Jul; 351(3):260-7. PubMed ID: 15254284
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for the development of thrombotic complication in patients with lupus erythematosus and lupus nephropatic].
Zaldívar-Alcántara H; Herrera-Jiménez LE; Dehesa-López E; Correa-Rotter R
Rev Invest Clin; 2013; 65(3):199-208. PubMed ID: 23877806
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
5. Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
Hinojosa-Azaola A; Romero-Diaz J; Vargas-Ruiz AG; Nuñez-Alvarez CA; Cicero-Casarrubias A; Ocampo-Torres MC; Sanchez-Guerrero J
J Rheumatol; 2016 Mar; 43(3):576-86. PubMed ID: 26773122
[TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.
Petri M; Roubenoff R; Dallal GE; Nadeau MR; Selhub J; Rosenberg IH
Lancet; 1996 Oct; 348(9035):1120-4. PubMed ID: 8888164
[TBL] [Abstract][Full Text] [Related]
7. Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings.
Provenzale JM; Ortel TL
AJR Am J Roentgenol; 1995 Aug; 165(2):365-8. PubMed ID: 7618558
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
9. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
Chang ER; Pineau CA; Bernatsky S; Neville C; Clarke AE; Fortin PR
J Rheumatol; 2006 Sep; 33(9):1780-4. PubMed ID: 16832849
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
11. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
[TBL] [Abstract][Full Text] [Related]
13. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
14. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
16. [The prediction of thrombosis development in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin].
Nasonov EL; Kovalev VIu; Alekberova ZS; Solov'ev SK
Ter Arkh; 1992; 64(5):25-30. PubMed ID: 1455369
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
18. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster in systemic lupus erythematosus.
Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
